Skip to main content
NCBI home page
International Journal of Experimental Pathology logoLink to International Journal of Experimental Pathology
. 1993 Feb;74(1):55–63.

The effect of cyclosporin A on rabbit nephrotoxic glomerulonephritis.

S Kurunczi 1, I Mark 1
PMCID: PMC2002223  PMID: 8471535

Abstract

The effect of cyclosporin A on the development of the autologous phase of experimental rabbit glomerulonephritis was assessed. The glomerulonephritis was induced by a single intravenous injection of duck anti-rabbit glomerular basement membrane globulin (molecular weight: 115 kDa) into adult rabbits. After 5-7 days, diffuse proliferative glomerulonephritis with proteinuria was observed in all the animals not treated with cyclosporin A (control group). The cyclosporin A treatment was started simultaneously with the injection of duck globulin. This attenuated the glomerular lesion, resulting in a normal urinary protein excretion. The serum level of autologous anti-duck IgG was reduced. In the group of rabbits which received an injection of duck anti-rabbit glomerular basement membrane globulin, cyclosporin A treatment and an additional high dose rabbit anti-duck globulin 8 days later again no glomerulonephritis was observed. However, cyclosporin A treatment had no effect on the observed duck immunoglobulin-induced passive Arthus phenomenon.

Full text

PDF
55

Images in this article

57Figure 3
on p.57
58Figure 4
on p.58
59Figure 5
on p.59
60Figure 6
on p.60
61Figure 7
on p.61
61Figure 8
on p.61
62Figure 9
on p.62
62Figure 10
on p.62

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akikusa B., Shigematsu H., Kondo Y. Cellular aspects of rabbit Masugi nephritis. IV. Cell quantitation of proliferative glomerulonephritis. Acta Pathol Jpn. 1979 Jul;29(4):509–522. doi: 10.1111/j.1440-1827.1979.tb00920.x. [DOI] [PubMed] [Google Scholar]
  2. Boesken W. H., Meinhart K., Rentsch I., Hammer D. K. Characterization of basement membrane antigens present in the urine of normal and nephritic rabbits. Int Arch Allergy Appl Immunol. 1972;43(2):232–251. doi: 10.1159/000230840. [DOI] [PubMed] [Google Scholar]
  3. Boyce N. W., Tipping P. G., Holdsworth S. R. Lymphokine (MIF) production by glomerular T-lymphocytes in experimental glomerulonephritis. Kidney Int. 1986 Nov;30(5):673–677. doi: 10.1038/ki.1986.239. [DOI] [PubMed] [Google Scholar]
  4. Brodehl J. Ciclosporin A bei glomerulären Erkrankungen. Internist (Berl) 1985 Sep;26(9):578–579. [PubMed] [Google Scholar]
  5. Brodehl J. Therapie der chronischen Glomerulonephritis. Kinderarztl Prax. 1985 Nov;53(11):523–529. [PubMed] [Google Scholar]
  6. Clarke B. E., Ham K. N., Tange J. D., Ryan G. B. Origin of glomerular crescents in rabbit nephrotoxic nephritis. J Pathol. 1983 Mar;139(3):247–258. doi: 10.1002/path.1711390303. [DOI] [PubMed] [Google Scholar]
  7. Dos Reis G. A., Shevach E. M. Effect of cyclosporin A on T cell function in vitro: the mechanism of suppression of T cell proliferation depends on the nature of the T cell stimulus as well as the differentiation state of the responding T cell. J Immunol. 1982 Dec;129(6):2360–2367. [PubMed] [Google Scholar]
  8. Grey H. M. Duck immunoglobulins. I. Structural studies on a 5.7S and 7.8S gamma-globulin. J Immunol. 1967 Apr;98(4):811–819. [PubMed] [Google Scholar]
  9. Helin H. J., Edgington T. S. Cyclosporin A regulates monocyte/macrophage effector functions by affecting instructor T cells: inhibition of monocyte procoagulant response to allogeneic stimulation. J Immunol. 1984 Mar;132(3):1074–1076. [PubMed] [Google Scholar]
  10. Hess A. D., Colombani P. N. Cyclosporin-resistant and -sensitive T-lymphocyte subsets. Ann Inst Pasteur Immunol. 1987 Jul-Aug;138(4):606–611. doi: 10.1016/s0769-2625(87)80131-9. [DOI] [PubMed] [Google Scholar]
  11. Holdsworth S. R. Fc dependence of macrophage accumulation and subsequent injury in experimental glomerulonephritis. J Immunol. 1983 Feb;130(2):735–739. [PubMed] [Google Scholar]
  12. Hruby Z., Lowry R. P., Forbes R. D., Marghesco D. Immune mechanisms and molecular mediators of glomerular injury in experimental nephritis. Summary of current results and continuing studies. Int Urol Nephrol. 1988;20(5):513–517. doi: 10.1007/BF02550613. [DOI] [PubMed] [Google Scholar]
  13. Kurunczi S., Dzengel M., Hosszu Z. Die Wirkung von Cyclosporin A auf die experimentelle Glomerulonephritis bei Kaninchen. Monatsschr Kinderheilkd. 1990 Apr;138(4):211–215. [PubMed] [Google Scholar]
  14. LOWRY O. H. Biochemical evidence of nutritional status. Physiol Rev. 1952 Oct;32(4):431–448. doi: 10.1152/physrev.1952.32.4.431. [DOI] [PubMed] [Google Scholar]
  15. Meyrier A., Simon P., Perret G., Condamin-Meyrier M. C. Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A. Br Med J (Clin Res Ed) 1986 Mar 22;292(6523):789–792. doi: 10.1136/bmj.292.6523.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Palay D. A., Cluff C. W., Wentworth P. A., Ziegler H. K. Cyclosporine inhibits macrophage-mediated antigen presentation. J Immunol. 1986 Jun 15;136(12):4348–4353. [PubMed] [Google Scholar]
  17. Spiro R. G. Studies on the renal glomerular basement membrane. Preparation and chemical composition. J Biol Chem. 1967 Apr 25;242(8):1915–1922. [PubMed] [Google Scholar]
  18. Tipping P. G., Holdsworth S. R. Effect of cyclosporin A on antibody-induced experimental glomerulonephritis. Nephron. 1985;40(2):201–205. doi: 10.1159/000190341. [DOI] [PubMed] [Google Scholar]
  19. Tipping P. G., Holdsworth S. R. Isolation and characterization of glomerular macrophages in experimental glomerulonephritis. Immunol Cell Biol. 1988 Apr;66(Pt 2):147–151. doi: 10.1038/icb.1988.18. [DOI] [PubMed] [Google Scholar]
  20. Tipping P. G., Neale T. J., Holdsworth S. R. T lymphocyte participation in antibody-induced experimental glomerulonephritis. Kidney Int. 1985 Mar;27(3):530–537. doi: 10.1038/ki.1985.43. [DOI] [PubMed] [Google Scholar]
  21. Wagner H., Hardt C., Heeg K. Wirkungsmechanismus des Ciclosporin A. Internist (Berl) 1985 Sep;26(9):530–533. [PubMed] [Google Scholar]
  22. Windom H. H., Fisher M., Neale T. J. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis. N Z Med J. 1990 Mar 28;103(886):125–126. [PubMed] [Google Scholar]
  23. Zimmerman B., Shalatin N., Grey H. M. Structural studies on the duck 5.7S and 7.8S immunoglobulins. Biochemistry. 1971 Feb 2;10(3):482–488. doi: 10.1021/bi00779a021. [DOI] [PubMed] [Google Scholar]
  24. van den Berg J. W., Verhoef M. L., de Boer A. J., Schalm S. W. Cyclosporin A assay: conditions for sampling and processing of blood. Clin Chim Acta. 1985 Apr 30;147(3):291–297. doi: 10.1016/0009-8981(85)90212-8. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES